Worldwide Clinical beefs up its U.S. business development with new hires

Worldwide Clinical Trials is beefing up its U.S. business development operations with new hires. (Pixabay)

Worldwide Clinical Trials is beefing up its U.S. business development operations with the additions of CRO industry experts Giovanna Chan and Cara Staley.

The two will lead the western and eastern U.S. regions, respectively, the company said.

Chan and Staley will report to Sara Davis, who joined Worldwide Clinical in June and was recently promoted to head its global commercial team. 


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

The moves are part of the company’s plan to expand its resources to meet expected demands from small and midsize pharmaceutical and biopharma organizations from CRO partners.

“Sponsors tell us they need their CRO partner to scale to manage global development portfolios, offer deep expertise and operational excellence to challenge the status quo, and innovate to reduce the time and cost of drug development,” Davis said in a statement.

In May, Worldwide partnered with Datavant to explore the reasons clinical trials in neurodegenerative diseases fail and how big data tactics can improve prolonged study monitoring and conduct. 

Suggested Articles

WIRB-Copernicus Group has added two new executives to its roster as it expands its Global Research Network of investigative sites.

Incoming FDA Commissioner Ned Sharpless used his first official talk to ensure we all know he’s not looking to tear up Scott Gottlieb’s legacy.

Charles River Labs and the CHDI Foundation have signed a five-year extension for their Huntington’s disease work.